Caristo Diagnostics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 60

Employees

  • Latest Deal Type
  • Series B
  • (Cancelled)

  • Investors
  • 11

Caristo Diagnostics General Information

Description

Developer of AI-powered technology designed to detect heart disease at its earliest stages. The company offers advanced algorithms that identify hidden heart attack risks before symptoms appear, enabling hospitals and healthcare providers to deliver early detection and personalized prevention to improve patient outcomes.

Contact Information

Website
www.caristo.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • New Barclay House
  • 234 Botley Road
  • Oxford OX2 0HP
  • England, United Kingdom
+44 01865
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Other Healthcare Services
Corporate Office
  • New Barclay House
  • 234 Botley Road
  • Oxford OX2 0HP
  • England, United Kingdom
+44 01865

Caristo Diagnostics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Caristo Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series B) Cancelled Generating Revenue
8. Accelerator/Incubator 25-Sep-2024 Completed Generating Revenue
7. Later Stage VC (Series A) 04-Apr-2023 Completed Generating Revenue
6. Early Stage VC (Series A) 26-Nov-2020 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2019 Completed Startup
4. Grant 08-Oct-2018 Completed Startup
3. Seed Round 26-Jul-2018 Completed Startup
2. Grant $2.5M Completed Startup
1. University Spin-Out 22-Feb-2018 Completed Startup
To view Caristo Diagnostics’s complete valuation and funding history, request access »

Caristo Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
A preferred
Ordinary
Ordinary
Ordinary 1,090 $0.001217 $33.52 $33.52 1x $33.52 0.22%
Ordinary 73,034 $0.001217 $33.48 $33.48 1x $33.48 15.03%
To view Caristo Diagnostics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Caristo Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of AI-powered technology designed to detect heart disease at its earliest stages. The company offers advanced
Diagnostic Equipment
Oxford, United Kingdom
60 As of 2025

Boston, MA
 

Denver, CO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Caristo Diagnostics Competitors (5)

One of Caristo Diagnostics’s 5 competitors is Elucid, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Elucid Venture Capital-Backed Boston, MA
Cleerly Venture Capital-Backed Denver, CO
Medis Medical Imaging Private Equity-Backed Leiden, Netherlands
Artrya Formerly VC-backed Perth, Australia
HeartFlow Formerly VC-backed Mountain View, CA
You’re viewing 5 of 5 competitors. Get the full list »

Caristo Diagnostics Patents

Caristo Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202404701-D0 Method Pending 02-Apr-2024
GB-2640131-A Method Pending 02-Apr-2024
AU-2025249798-A1 Method for determining the presence or risk of disease and/or vascular state in a subject Pending 02-Apr-2024
WO-2025210350-A1 Method for determining the presence or risk of disease and/or vascular state in a subject Pending 02-Apr-2024
GB-202402532-D0 Method Pending 22-Feb-2024 G06T7/0012
To view Caristo Diagnostics’s complete patent history, request access »

Caristo Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Caristo Diagnostics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
HeartX Accelerator Accelerator/Incubator Minority
HTA (Little Rock) Accelerator/Incubator Minority
MedAxiom Corporation Minority
BGF (Financial Services) Growth/Expansion Minority
Oxford Technology Investment Fund Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Caristo Diagnostics FAQs

  • When was Caristo Diagnostics founded?

    Caristo Diagnostics was founded in 2018.

  • Where is Caristo Diagnostics headquartered?

    Caristo Diagnostics is headquartered in Oxford, United Kingdom.

  • What is the size of Caristo Diagnostics?

    Caristo Diagnostics has 60 total employees.

  • What industry is Caristo Diagnostics in?

    Caristo Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Caristo Diagnostics a private or public company?

    Caristo Diagnostics is a Private company.

  • What is Caristo Diagnostics’s current revenue?

    The current revenue for Caristo Diagnostics is .

  • How much funding has Caristo Diagnostics raised over time?

    Caristo Diagnostics has raised $30.5M.

  • Who are Caristo Diagnostics’s investors?

    HeartX Accelerator, HTA (Little Rock), MedAxiom, BGF (Financial Services), and Oxford Technology Investment Fund are 5 of 11 investors who have invested in Caristo Diagnostics.

  • Who are Caristo Diagnostics’s competitors?

    Elucid, Cleerly, Medis Medical Imaging, Artrya, and HeartFlow are competitors of Caristo Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process